8-K Announcements
6Material company update
Apr 3, 2026·SEC
Material company update
Mar 30, 2026·SEC
Material company update
Mar 16, 2026·SEC
Phreesia, Inc.(PHR)Earnings, Financials & Key Ratios
PHR•NYSE
$9.53
$575M mkt cap·Price updated May 6, 2026
AboutPhreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.Show more
- Revenue$420M+17.8%
- EBITDA-$30M+71.5%
- Net Income-$59M+57.2%
- EPS (Diluted)-1.02+59.4%
- Gross Margin67.86%+4.1%
- EBITDA Margin-7.2%+75.8%
- Operating Margin-13.84%+63.9%
- Net Margin-13.94%+63.7%
- ROE-22.67%+55.3%
- ROIC-23.28%+66.3%
- Debt/Equity0.07+41.1%
- Interest Coverage-24.75+66.4%
PHR Key Insights
Phreesia, Inc. (PHR) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y sales CAGR of 27.5%
- ✓Efficient asset utilization: 1.1x turnover
✗Weaknesses
- ✗Weak momentum: RS Rating 7 (bottom 7%)
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
PHR Price & Volume
Phreesia, Inc. (PHR) stock price & volume — 10-year historical chart
Loading chart...
PHR Growth Metrics
Phreesia, Inc. (PHR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years27.46%
3 Years25.33%
TTM14.33%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM93.5%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM84.21%
Return on Capital
10 Years-32.74%
5 Years-33.4%
3 Years-40.17%
Last Year-21.73%
PHR Recent Earnings
Phreesia, Inc. (PHR) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
Mar 30, 2026EPS
$0.12
Est $0.07
+82.6%
Revenue
$127M
Est $127M
+0.2%
Q4 2025
Dec 8, 2025EPS
$0.10
Est $0.00
Revenue
$120M
Est $120M
+0.3%
Q4 2025
Sep 4, 2025EPS
$0.01
Est $0.07
+114.3%
Revenue
$117M
Est $120M
-2.4%
Q2 2025
May 28, 2025EPS
$0.07
Est $0.13
+46.2%
Revenue
$116M
Est $116M
-0.3%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 30, 2026 | $0.12vs $0.07+82.6% | $127Mvs $127M+0.2% |
| Q4 2025 | Dec 8, 2025 | $0.10vs $0.00 | $120Mvs $120M+0.3% |
| Q4 2025 | Sep 4, 2025 | $0.01vs $0.07+114.3% | $117Mvs $120M-2.4% |
| Q2 2025 | May 28, 2025 | $0.07vs $0.13+46.2% | $116Mvs $116M-0.3% |
Based on last 12 quarters of dataView full earnings history →
PHR Peer Comparison
Phreesia, Inc. (PHR) competitors in Patient Engagement, Intake and Payments — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HCAT | 111.47M | 1.57 | -0.62 | 1.48% | -57.2% | -54.67% | 0.08 | |
 DOCS | 5.17B | 25.69 | 23.14 | 19.98% | 37.54% | 24.45% | 0.01 | |
 GDRX | 880.73M | 2.57 | 30.13 | 0.57% | 3.74% | 4.75% | 0.10 | |
 VEEV | 27.2B | 167.29 | 30.75 | 16.34% | 28.44% | 13.41% | 0.01 | |
 INVA | 1.91B | 22.52 | 6.82 | 18.52% | 118.91% | 46.47% | 0.23 | |
 TDOC | 1.23B | 6.80 | -5.96 | -1.54% | -6.81% | -12.37% | 0.75 | |
 AMWL | 119.11M | 7.15 | -1.20 | -1.98% | -48.16% | -33.48% | 0.02 | |
 PGNY | 1.53B | 18.70 | 28.77 | 10.4% | 4.54% | 11.37% | 0.05 |
Compare PHR vs Peers
Phreesia, Inc. (PHR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
PHR Income Statement
Phreesia, Inc. (PHR) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 79.83M | 99.89M | 124.78M | 148.68M | 213.23M | 280.91M | 356.3M | 419.81M | 463.2M |
| Revenue Growth % | - | 25.12% | 24.92% | 19.15% | 43.42% | 31.74% | 26.84% | 17.83% | 14.33% |
| Cost of Goods Sold | 29.77M | 37M | 44.72M | 52.39M | 81.39M | 109.27M | 124.01M | 134.93M | 147.3M |
| COGS % of Revenue | 37.29% | 37.04% | 35.84% | 35.23% | 38.17% | 38.9% | 34.81% | 32.14% | - |
| Gross Profit | 50.06M▲ 0% | 62.89M▲ 25.6% | 80.06M▲ 27.3% | 96.29M▲ 20.3% | 131.84M▲ 36.9% | 171.64M▲ 30.2% | 232.29M▲ 35.3% | 284.88M▲ 22.6% | 315.91M▲ 0% |
| Gross Margin % | 62.71% | 62.96% | 64.16% | 64.77% | 61.83% | 61.1% | 65.19% | 67.86% | 68.2% |
| Gross Profit Growth % | - | 25.62% | 27.3% | 20.27% | 36.92% | 30.19% | 35.33% | 22.64% | - |
| Operating Expenses | 64.62M | 72.39M | 95.36M | 121.96M | 248.66M | 348.19M | 368.77M | 342.98M | 324.57M |
| OpEx % of Revenue | 80.94% | 72.47% | 76.42% | 82.03% | 116.62% | 123.95% | 103.5% | 81.7% | - |
| Selling, General & Admin | 43.6M | 46.44M | 62.81M | 83.43M | 175.09M | 231.65M | 226.93M | 197.73M | 175.8M |
| SG&A % of Revenue | 54.61% | 46.49% | 50.34% | 56.12% | 82.11% | 82.46% | 63.69% | 47.1% | - |
| Research & Development | 11.38M | 14.35M | 18.62M | 22.62M | 52.27M | 91.24M | 112.35M | 117.36M | 120.18M |
| R&D % of Revenue | 14.25% | 14.37% | 14.92% | 15.22% | 24.51% | 32.48% | 31.53% | 27.96% | - |
| Other Operating Expenses | 9.64M | 11.59M | 13.92M | 15.91M | 21.3M | 25.3M | 29.49M | 27.89M | 4M |
| Operating Income | -14.55M▲ 0% | -9.49M▲ 34.8% | -15.3M▼ 61.1% | -25.67M▼ 67.8% | -116.82M▼ 355.1% | -176.55M▼ 51.1% | -136.48M▲ 22.7% | -58.1M▲ 57.4% | -8.67M▲ 0% |
| Operating Margin % | -18.23% | -9.5% | -12.26% | -17.27% | -54.78% | -62.85% | -38.3% | -13.84% | -1.87% |
| Operating Income Growth % | - | 34.76% | -61.14% | -67.81% | -355.05% | -51.14% | 22.7% | 57.43% | - |
| EBITDA | -3.52M | 2.1M | -1.37M | -7.74M | -92.3M | -147.78M | -105.94M | -30.21M | 20.03M |
| EBITDA Margin % | -4.41% | 2.1% | -1.1% | -5.2% | -43.29% | -52.61% | -29.73% | -7.2% | 4.32% |
| EBITDA Growth % | - | 159.61% | -165.42% | -463.17% | -1092.81% | -60.11% | 28.32% | 71.48% | 139.93% |
| D&A (Non-Cash Add-back) | 11.03M | 11.59M | 13.92M | 17.93M | 24.52M | 28.77M | 30.54M | 27.89M | 28.7M |
| EBIT | -14.55M | -9.49M | -19.03M | -25.55M | -116.82M | -174.25M | -133.49M | -53.46M | -2.26M |
| Net Interest Income | -3.64M | -3.5M | -2.44M | -1.57M | -1.08M | 1.06M | 2.21M | 330K | 775K |
| Interest Income | 401 | 185 | 598K | 122K | 79K | 2.48M | 4.07M | 2.68M | 3.01M |
| Interest Expense | 3.64M | 3.5M | 3.04M | 1.7M | 1.16M | 1.41M | 1.85M | 2.35M | 2.24M |
| Other Income/Expense | -3.64M | -5.57M | -6.78M | -1.57M | -1.16M | 889K | 1.14M | 2.29M | 4.67M |
| Pretax Income | -18.19M▲ 0% | -15.06M▲ 17.2% | -22.07M▼ 46.5% | -27.24M▼ 23.4% | -117.98M▼ 333.1% | -175.66M▼ 48.9% | -135.34M▲ 23.0% | -55.81M▲ 58.8% | -3.99M▲ 0% |
| Pretax Margin % | -22.79% | -15.08% | -17.69% | -18.32% | -55.33% | -62.53% | -37.99% | -13.29% | -0.86% |
| Income Tax | 0 | -2.06M | -1.78M | 49K | 182K | 483K | 1.54M | 2.72M | 1.39M |
| Effective Tax Rate % | 0% | 13.7% | 8.06% | -0.18% | -0.15% | -0.27% | -1.14% | -4.87% | -34.71% |
| Net Income | -18.19M▲ 0% | -15.06M▲ 17.2% | -20.29M▼ 34.7% | -27.29M▼ 34.5% | -118.16M▼ 333.0% | -176.15M▼ 49.1% | -136.88M▲ 22.3% | -58.53M▲ 57.2% | -5.38M▲ 0% |
| Net Margin % | -22.79% | -15.08% | -16.26% | -18.36% | -55.41% | -62.71% | -38.42% | -13.94% | -1.16% |
| Net Income Growth % | - | 17.21% | -34.73% | -34.49% | -332.95% | -49.07% | 22.29% | 57.24% | 93.5% |
| Net Income (Continuing) | -18.19M | -15.06M | -20.29M | -27.29M | -118.16M | -176.15M | -136.88M | -58.53M | -5.38M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -11.82▲ 0% | -8.16▲ 31.0% | -1.00▲ 87.7% | -0.69▲ 31.0% | -2.37▼ 243.5% | -3.36▼ 41.8% | -2.51▲ 25.3% | -1.02▲ 59.4% | -0.09▲ 0% |
| EPS Growth % | - | 30.96% | 87.75% | 31% | -243.48% | -41.77% | 25.3% | 59.36% | 84.21% |
| EPS (Basic) | -11.82 | -8.16 | -1.00 | -0.69 | -2.37 | -3.36 | -2.51 | -1.02 | - |
| Diluted Shares Outstanding | 1.54M | 1.84M | 20.3M | 39.52M | 49.89M | 52.44M | 54.56M | 57.59M | 61.49M |
| Basic Shares Outstanding | 1.54M | 1.84M | 20.3M | 39.52M | 49.89M | 52.44M | 54.56M | 57.59M | 59.51M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
PHR Balance Sheet
Phreesia, Inc. (PHR) balance sheet — assets, liabilities & shareholders' equity
| Line item | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 35.95M | 32.88M | 131.54M | 272.27M | 386.35M | 262.44M | 195.68M | 203.28M | 240.91M |
| Cash & Short-Term Investments | 10.5M | 1.54M | 90.31M | 218.78M | 313.81M | 176.68M | 87.52M | 84.22M | 106.37M |
| Cash Only | 10.5M | 1.54M | 90.31M | 218.78M | 313.81M | 176.68M | 87.52M | 84.22M | 106.37M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 12.31M | 26.29M | 21.98M | 29.05M | 40.26M | 51.39M | 64.86M | 73.62M | 88.26M |
| Days Sales Outstanding | 56.28 | 96.07 | 64.29 | 71.32 | 68.92 | 66.78 | 66.45 | 64.01 | 68.32 |
| Inventory | 1.64M | 1.67M | 6.88M | 8.95M | 1.64M | 1.06M | 768K | 0 | 0 |
| Days Inventory Outstanding | 20.1 | 16.5 | 56.13 | 62.34 | 7.36 | 3.53 | 2.26 | - | - |
| Other Current Assets | 8.68M | 1.67M | 13.26M | 15.49M | 21.74M | 25.94M | 32.48M | 34.13M | 46.28M |
| Total Non-Current Assets | 21.18M | 26.38M | 27.22M | 54.4M | 108.13M | 107.62M | 174.64M | 185.13M | 182.57M |
| Property, Plant & Equipment | 13.17M | 14.21M | 14.49M | 29.31M | 36.98M | 22.24M | 17.17M | 25.13M | 22.68M |
| Fixed Asset Turnover | 6.06x | 7.03x | 8.61x | 5.07x | 5.77x | 12.63x | 20.75x | 16.71x | 19.04x |
| Goodwill | 0 | 250.19K | 250K | 8.31M | 33.62M | 33.74M | 75.84M | 75.84M | 75.84M |
| Intangible Assets | 6.72M | 9.25M | 9.93M | 13.2M | 30.41M | 46.55M | 77.76M | 80.91M | 25.53M |
| Long-Term Investments | 81.87K | 0 | 1.59M | 1.25M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.3M | 2.67M | 180K | 1.67M | 6.59M | 5.01M | 3.87M | 3.25M | 121.05M |
| Total Assets | 57.14M▲ 0% | 59.26M▲ 3.7% | 158.76M▲ 167.9% | 326.67M▲ 105.8% | 494.48M▲ 51.4% | 370.06M▼ 25.2% | 370.33M▲ 0.1% | 388.42M▲ 4.9% | 423.47M▲ 0% |
| Asset Turnover | 1.40x | 1.69x | 0.79x | 0.46x | 0.43x | 0.76x | 0.96x | 1.08x | 1.14x |
| Asset Growth % | - | 3.72% | 167.89% | 105.76% | 51.37% | -25.16% | 0.07% | 4.88% | 37.8% |
| Total Current Liabilities | 24.98M | 27.93M | 35.35M | 54.99M | 68.43M | 79.04M | 110.12M | 114.02M | 98.78M |
| Accounts Payable | 2.2M | 3.75M | 6.02M | 4.39M | 5.12M | 10.84M | 8.48M | 5.62M | 6.22M |
| Days Payables Outstanding | 27 | 37 | 49.11 | 30.58 | 22.96 | 36.2 | 24.96 | 15.21 | 13.36 |
| Short-Term Debt | 1.17M | 97K | 2.32M | 4.86M | 221K | 246K | 1.1M | 1.22M | 0 |
| Deferred Revenue (Current) | 4.89M | 6.49M | 5.4M | 10.84M | 16.49M | 17.69M | 24.11M | 32.76M | 120.53M |
| Other Current Liabilities | 8.68M | 10.22M | 16.58M | 24.87M | 32.45M | 32.57M | 53.16M | 844K | 69.07M |
| Current Ratio | 1.44x | 1.18x | 3.72x | 4.95x | 5.65x | 3.32x | 1.78x | 1.78x | 1.78x |
| Quick Ratio | 1.37x | 1.12x | 3.53x | 4.79x | 5.62x | 3.31x | 1.77x | 1.78x | 1.78x |
| Cash Conversion Cycle | 49.37 | 75.57 | 71.31 | 103.08 | 53.32 | 34.11 | 43.75 | - | 54.96 |
| Total Non-Current Liabilities | 199.84M | 242.31M | 21.54M | 8.37M | 8.76M | 3.2M | 8.76M | 9.58M | 4.36M |
| Long-Term Debt | 19.45M | 27.92M | 21.54M | 6.47M | 8.7M | 3.07M | 2.05M | 719K | 3.48M |
| Capital Lease Obligations | 652.41K | 2.4M | 2.1M | 1.9M | 8.7M | 3.07M | 3.48M | 8.08M | 12.51M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 2.77M | 2.71M | 1.35M | 270K | 484K | 2.36M |
| Other Non-Current Liabilities | 179.73M | 211.99M | -2.1M | 0 | -8.7M | -3.07M | 2.86M | 185K | 668K |
| Total Liabilities | 224.82M | 270.24M | 56.89M | 63.36M | 77.2M | 82.24M | 118.88M | 123.61M | 103.14M |
| Total Debt | 22.93M | 32.29M | 23.86M | 14.32M | 15.8M | 9.18M | 11.98M | 17.8M | 3.48M |
| Net Debt | 12.43M | 30.74M | -66.45M | -204.46M | -298.01M | -167.5M | -75.54M | -66.42M | -102.89M |
| Debt / Equity | - | - | 0.23x | 0.05x | 0.04x | 0.03x | 0.05x | 0.07x | 0.07x |
| Debt / EBITDA | - | 15.37x | - | - | - | - | - | - | 0.17x |
| Net Debt / EBITDA | - | 14.64x | - | - | - | - | - | - | -5.14x |
| Interest Coverage | -4.00x | -2.71x | -5.03x | -15.15x | -100.44x | -125.13x | -73.61x | -24.75x | -1.01x |
| Total Equity | -167.68M▲ 0% | -210.97M▼ 25.8% | 101.86M▲ 148.3% | 263.31M▲ 158.5% | 417.28M▲ 58.5% | 287.82M▼ 31.0% | 251.45M▼ 12.6% | 264.81M▲ 5.3% | 320.33M▲ 0% |
| Equity Growth % | - | -25.82% | 148.28% | 158.49% | 58.48% | -31.03% | -12.64% | 5.31% | 61.34% |
| Book Value per Share | -108.98 | -114.35 | 5.02 | 6.66 | 8.36 | 5.49 | 4.61 | 4.60 | 5.21 |
| Total Shareholders' Equity | -167.68M | -210.97M | 101.86M | 263.31M | 417.28M | 287.82M | 251.45M | 264.81M | 320.33M |
| Common Stock | 16.38K | 19.95K | 366K | 449K | 521K | 542K | 577K | 601K | 616K |
| Retained Earnings | -167.7M | -210.99M | -284.49M | -311.78M | -429.94M | -606.08M | -742.97M | -801.5M | -800.49M |
| Treasury Stock | 0 | 0 | -399K | -4.96M | -13.96M | -33.6M | -45.52M | -45.52M | 0 |
| Accumulated OCI | -20.33M | -27.86M | -158.76M | 0 | 0 | 0 | 0 | -51K | -360K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PHR Cash Flow Statement
Phreesia, Inc. (PHR) cash flow — operating, investing & free cash flow history
| Line item | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -11.14M | -2.13M | 826K | 2.89M | -74.71M | -90.12M | -32.38M | 32.38M | 32.38M |
| Operating CF Margin % | -13.96% | -2.13% | 0.66% | 1.94% | -35.04% | -32.08% | -9.09% | 7.71% | - |
| Operating CF Growth % | - | 80.88% | 138.78% | 249.88% | -2685.12% | -20.63% | 64.07% | 200.01% | 2677.34% |
| Net Income | -18.19M | -15.06M | -20.29M | -27.29M | -118.16M | -176.15M | -136.88M | -58.53M | -5.38M |
| Depreciation & Amortization | 9.64M | 11.59M | 13.92M | 15.91M | 21.3M | 25.3M | 29.49M | 27.89M | 28.59M |
| Stock-Based Compensation | 805K | 1.45M | 6.18M | 13.49M | 36.14M | 58.77M | 71.7M | 66.97M | 66.58M |
| Deferred Taxes | 598K | 2.06M | -775K | -65K | 143K | 434K | 228K | 214K | -1.4M |
| Other Non-Cash Items | 2.29M | 1.38M | 7.54M | 4.94M | 4.43M | 5.37M | 4.73M | 2.33M | -12.66M |
| Working Capital Changes | -6.29M | -3.55M | -5.75M | -4.09M | -18.57M | -3.86M | -1.64M | -6.49M | -14.32M |
| Change in Receivables | -3.38M | -3.8M | -5.91M | -6.62M | -10.22M | -11.13M | -11.21M | -8.81M | -17.02M |
| Change in Inventory | 1.65M | -2.45M | 3.37M | 2.62M | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -2.06M | 1.96M | -30K | -3.82M | 2.88M | 4.77M | -1.99M | -3.23M | -6.8M |
| Cash from Investing | -11.96M | -11.02M | -12.32M | -25.09M | -65.23M | -26.2M | -39.67M | -24.09M | -26.32M |
| Capital Expenditures | -11.96M | -9.83M | -12.32M | -18.57M | -30.8M | -26.2M | -5.81M | -8.71M | -11.33M |
| CapEx % of Revenue | 14.99% | 9.84% | 9.87% | 12.49% | 14.45% | 9.33% | 1.63% | 2.07% | - |
| Acquisitions | 0 | -1.19M | 0 | -6.51M | -34.42M | 0 | -14.57M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | -5.38M | -5.11M | -5.3M | -7.33M | -12.38M | -21.47M | -19.29M | -15.38M | -14.99M |
| Cash from Financing | 31.29M | 4.19M | 100.27M | 150.66M | 234.97M | -20.41M | -17.11M | -11.49M | -10.28M |
| Debt Issued (Net) | -1.1M | 4.03M | -11.15M | -25.21M | -4.27M | -5.73M | -6.78M | -7.81M | -7.34M |
| Equity Issued (Net) | 1000K | 0 | 1000K | 1000K | 1000K | 1000K | -1000K | 1000K | 817K |
| Dividends Paid | 0 | 0 | -14.96M | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -4.96M | -8.99M | -19.38M | -12.18M | 0 | 0 |
| Other Financing | -77K | 165.63K | -4.41M | 6.04M | 2.42M | -20M | 1.84M | -7.61M | -3.75M |
| Net Change in Cash | 8.18M▲ 0% | -8.96M▼ 209.5% | 88.77M▲ 1090.7% | 128.47M▲ 44.7% | 95.03M▼ 26.0% | -137.13M▼ 244.3% | -89.16M▲ 35.0% | -3.3M▲ 96.3% | 24.63M▲ 0% |
| Free Cash Flow | -23.11M▲ 0% | -11.96M▲ 48.2% | -11.49M▲ 3.9% | -15.69M▼ 36.5% | -105.52M▼ 572.7% | -116.33M▼ 10.2% | -57.48M▲ 50.6% | 8.29M▲ 114.4% | 41.92M▲ 0% |
| FCF Margin % | -28.94% | -11.98% | -9.21% | -10.55% | -49.48% | -41.41% | -16.13% | 1.98% | 9.05% |
| FCF Growth % | - | 48.23% | 3.92% | -36.46% | -572.71% | -10.25% | 50.59% | 114.43% | 612.22% |
| FCF per Share | -15.02 | -6.48 | -0.57 | -0.40 | -2.12 | -2.22 | -1.05 | 0.14 | 0.14 |
| FCF Conversion (FCF/Net Income) | 0.61x | 0.14x | -0.04x | -0.11x | 0.63x | 0.51x | 0.24x | -0.55x | -7.79x |
| Interest Paid | 0 | 0 | 0 | 1.47M | 802K | 763K | 1.31M | 2.19M | 330K |
| Taxes Paid | 0 | 0 | 0 | 64K | 49K | 39K | 37K | 3.07M | 1.27M |
PHR Key Ratios
Phreesia, Inc. (PHR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | -19.92% | -14.95% | -34.72% | -49.96% | -50.77% | -22.67% | -1.68% |
| Return on Invested Capital (ROIC) | - | -32.4% | -40.85% | -98.38% | -110.54% | -69.11% | -23.28% | -23.28% |
| Gross Margin | 62.96% | 64.16% | 64.77% | 61.83% | 61.1% | 65.19% | 67.86% | 68.2% |
| Net Margin | -15.08% | -16.26% | -18.36% | -55.41% | -62.71% | -38.42% | -13.94% | -1.16% |
| Debt / Equity | - | 0.23x | 0.05x | 0.04x | 0.03x | 0.05x | 0.07x | 0.07x |
| Interest Coverage | -2.71x | -5.03x | -15.15x | -100.44x | -125.13x | -73.61x | -24.75x | -1.01x |
| FCF Conversion | 0.14x | -0.04x | -0.11x | 0.63x | 0.51x | 0.24x | -0.55x | -7.79x |
| Revenue Growth | 25.12% | 24.92% | 19.15% | 43.42% | 31.74% | 26.84% | 17.83% | 14.33% |
PHR SEC Filings & Documents
Phreesia, Inc. (PHR) SEC filings — annual & quarterly reports (10-K, 10-Q)
PHR Frequently Asked Questions
Phreesia, Inc. (PHR) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Phreesia, Inc. (PHR) reported $463.2M in revenue for fiscal year 2025. This represents a 480% increase from $79.8M in 2018.
Phreesia, Inc. (PHR) grew revenue by 17.8% over the past year. This is strong growth.
Phreesia, Inc. (PHR) reported a net loss of $5.4M for fiscal year 2025.
Dividend & Returns
Phreesia, Inc. (PHR) has a return on equity (ROE) of -22.7%. Negative ROE indicates the company is unprofitable.
Phreesia, Inc. (PHR) generated $41.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More PHR
Phreesia, Inc. (PHR) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates